TrialObesity (Silver Spring, Md.)2023

Glucagon-like peptide-1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial.

Karen D Corbin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.